top of page
AxiomCrossroads_Logo_wht.png
DSC04461.jpg
DSC04461.jpg
DSC04949.jpg
DSC04496.jpg

AXIOM CROSSROADS SUMMIT

The biopharma ecosystem stands at a crossroads. With anemic R&D delivery, failed clinical trials, access challenges, declining valuations, escalating clinical trial costs, patient identification, the hurdles we face are significant. Listen to leading experts from academia, biopharma, and the investment community discuss strategies to navigate these in oncology and rare diseases.

SUMMIT FACULTY

AxiomCrossroads_Panelist12.png

Paul
Biondi

AxiomCrossroads_Panelist7.png

Michelle
Werner

AxiomCrossroads_Panelist5.png

Giovanni
Abbadessa

AxiomCrossroads_Panelist13.png

Irina
Margine

AxiomCrossroads_Panelist10.png

Fatma
Ocak

AxiomCrossroads_Panelist.png

Biren
Amin

AxiomCrossroads_Panelist2.png

Uciane
Scarlett

AxiomCrossroads_Panelist6.png

Robert
LaCaze

AxiomCrossroads_Panelist3.png

Shruti
Agrawal

AxiomCrossroads_Panelist9.png

Lea
Hachigian

AxiomCrossroads_Panelist14.png

Christiana
Bardon

AxiomCrossroads_Panelist8.png

Alan
Bash

AxiomCrossroads_Panelist16.png

Lisa
Mahnke

AxiomCrossroads_Panelist15.png

Gaurav
Kandhari

AxiomCrossroads_Panelist11.png

Corey
Langer

AxiomCrossroads_Panelist4.png

Hossein
Borghaei

SUMMIT SESSIONS

Axiom Crossroads: Between Oncology and Rare Diseases
Axiom Crossroads: Best Foot Forward
Axiom Crossroads: Reimagining Clinical Trials
Axiom Crossroads: CEO and Founder Spotlight
Axiom Crossroads: Go-To-Market Strategies
Axiom Crossroads: Partnering for Innovation with Paul Biondi
Axiom Crossroads: Industry at a Crossroads
Axiom Crossroads: Innovation Where It Is Needed Most

"Thanks to team Axiom for hosting and to all the speakers and panelists for sharing their knowledge, insights and wisdom!!!"

_edited.png

LISTEN HERE

bottom of page